None listed
Conditions
Interventions
Procedure/Surgery : A facet joint block in which drugs are administered directly to the lumbar facet joint that had undergone 1 level OLIF was performed immediately after surgery.
At this time, 20mg o
Sponsors
Kyungpook National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) 20 years of age or older 2) Due to one of the following degenerative lumbar diseases Those who require oblique lateral lumbar interbody fusion in L3-4 or L4-5 single segment ? Spinal stenosis ? herniated disc ? Spondylolisthesis or spondylolysis 3) Adhere to treatment and procedures and observe all Those who are willing to visit the hospital for evaluation 4) A person who voluntarily signed a written consent after hearing the explanation about the purpose and method of this observational study
Exclusion criteria
Exclusion criteria: 1) Patients with severe osteoporosis (e.g., on DEXA bone density test, the mean T-score of lumbar L1-L4 < -4.0, or for young women, Z-score < -3.0 osteoporosis factor) 2) fracture of the application site (osteoporotic vertebral fracture, spine trauma fracture), subjects with acute infection, patients with the hemorrhagic disease, and patients with osteogenic disorders 3) Those with a history of fusion at the site of application 4) Those with a history of malignant tumors (the disease has been cured and Enrollment is possible if there has been no recurrence within 5 years) 5) Pregnant, lactating, or pregnant during this clinical trial You are planning or do not agree to a medically accepted method of contraception. those who do not 7) After being diagnosed with any of the following diseases, the operation proceeded. those who are judged to be difficult ? Uncontrolled diabetes, high blood pressure ? Mental illness: When it is difficult to conduct or comply with a clinical trial ? Drug and alcohol addiction ? Liver disease: liver cancer, cirrhosis, acute/chronic hepatitis ? Kidney disease: acute/chronic renal failure, excretory dysfunction ? Heart disease: severe heart failure ? Respiratory disease: active tuberculosis ? Infectious disease: active systemic infection and application site infection ? Metabolic diseases: rickets, osteomalacia, Paget's disease, pituitary dysfunction, (para)thyroid dysfunction, other bone metabolic disorders 8) It is difficult to conduct this observational study due to the judgment of the principal investigator patients who are considered to be
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analog scale for back pain | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions | — |
Countries
Korea, Republic of
Contacts
Public ContactSang-Woo Lee
Kyungpook National University Hospital
Outcome results
None listed